Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abidec is a multivitamin supplement primarily used for the prevention and treatment of vitamin deficiencies in infants and children. It is formulated to support healthy growth, bone development, immune function, and metabolic health. The product typically contains a balanced combination of essential vitamins, including Vitamin A (retinol), Vitamin D2 (ergocalciferol), Vitamin C (ascorbic acid), and several B-complex vitamins such as thiamine (B1), riboflavin (B2), pyridoxine (B6), and nicotinamide (B3). Vitamin A and D act as agonists for the retinoic acid and vitamin D receptors, respectively, while the B vitamins serve as essential cofactors in various enzymatic reactions. Abidec is widely available as oral drops or syrup and is marketed by companies including Sygen Pharmaceuticals and Perrigo (Omega Pharma).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Abidec.